Importantly, targeting SOX9 by either small interfering RNAs (siRNAs) or microRNAs significantly reduced tumor cell proliferation and invasion, chondrogenic differentiation in human mesenchymal stem cells, or resistance to targeted therapy for lung adenocarcinoma [14–16]. Here, SOX9 is linked to neoplasm.